Repair by Src kinase of function-impaired RET with multiple endocrine neoplasia type 2A mutation with substitutions of tyrosines in the COOH-terminal kinase domain for phenylalanine

Cancer Research

Volumn 62, Issue 8, 2002, Pages 2414-2422

  Kato, Masashi ^a   Takeda, Kozue ^a   Kawamoto, Yoshiyuki ^a   Iwashita, Toshihide ^a   Akhand, Anwarul A ^a   Senga, Takeshi ^a   Yamamoto, Masahiko ^a   Sobue, Gen ^a   Hamaguchi, Michinari ^a   Takahashi, Masahide ^a   Nakashima, Izumi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE; PHOSPHOAMINO ACID; PROTEIN RET; PROTEIN TYROSINE KINASE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME RECONSTITUTION; GENE MUTATION; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE;

3T3 CELLS; AMINO ACID SUBSTITUTION; ANIMALS; CATALYSIS; CELL TRANSFORMATION, NEOPLASTIC; DROSOPHILA PROTEINS; HUMANS; MICE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MUTAGENESIS; PHENYLALANINE; PHOSPHORYLATION; PHOSPHOTYROSINE; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; SRC-FAMILY KINASES; TRANSFECTION; TYROSINE;

EID: 0037089461     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor ret
2. The role of the ret proto-oncogene in human disease. The role of the ret proto-oncogene in human disease
3. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
4. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
5. Single missense mutation in the tyrosine-kinase catalytic domain of the RET proto-oncogene is associated with multiple endocrine neoplasia type 2B
6. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma
7. Mutations of the RET proto-oncogene in Hirschsprung's disease
8. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease
9. Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN 2A or MEN2B mutation
10. A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with Shc adaptor proteins
11. The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cγ
12. Oncogenic RET receptors display different autophosphorylation sites and substrate binding specificities
13. Ret transforming gene encodes a fusion protein homologous to tyrosine kinases
14. cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily
15. Three-dimensional structure of the tyrosine kinase c-Src
16. lck
17. Ultraviolet induces redox reaction-mediated dimerization and superactivation of oncogenic Ret tyrosine kinases
18. Molecular mechanism of activation and superactivation of Ret tyrosine kinases by ultraviolet light irradiation
19. Oncogenes and signal transduction
20. Functional rafts in cell membranes
21. Microdomains in lymphocyte signalling: Beyond GPI-anchored proteins
22. Nitric oxide controls Src kinase activity through a redox-based molecular modification
23. Src family kinases are required for integrin but not PDGFR signal transduction
24. RET tyrosine kinase enhances hair growth in association with promotion of melanogenesis
25. Characterization of the ret proto-oncogene products expressed in mouse L cells
26. Related articles isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses
27. Differential effects of leukocyte common antigen-related protein on biochemical and biological activities of RET-MEN2A and RET-MEN2B mutant proteins
28. Preserved phosphorylation of RET receptor protein in spinal motor neurons of patients with amyotrophic lateral sclerosis: An immunohistochemical study by a phosphorylation-specific antibody at tyrosine 1062
29. Linkage between melanocytic tumor development and early burst of Ret protein expression for tolerance induction in metallothionein-I/ret transgenic mouse lines
30. Transgenic mouse model for skin malignant melanoma
31. Evidence of a novel redox-linked activation mechanism for the Src kinase which is independent of tyrosine 527-mediated regulation
32. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T-cell activation
33. Ret-mediated mitogenesis requires Src kinase activity
34. GFRα-mediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival
35. Regulation, substrates, and functions of src
36. Palmitoylation of an amino-terminal cysteine motif of protein tyrosine kinase p56lck and p59fyn mediates interactions with glycosyl-phosphatidylinositol-anchored protein
37. Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations
38. Functional analysis of ret with Hirschsprung mutations affecting its kinase domain
39. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor
40. Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction
41. c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a phosphatidylinositol-3 kinase (PI-3K)-dependent pathway